EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Single‐Molecule Pleuripotent Scaffold for Combinational Therapy of Alzheimer's Disease via Intranasal Administration

Jian-Mei Gao, Wen-Bo Li, Na-Na Chen, Yang Yi, Ze-Han Wang, Xian Chen, Yang-Yang Zhao, Ze-Li Yuan, Jie Gao, Yu-Chen Pan, Dong-Sheng Guo iD, Qi-Hai Gong

Advanced Science · 2025

DOI: 10.1002/advs.202511611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jian-Mei Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Min…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Government-Guided Local S&T Special Project of Guizhou Province, "'hundred"' level of high-level innovative talents in Guizhou Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intricate pathological mechanisms of Alzheimer's disease (AD), along with the restrictive nature of the blood‐brain barrier (BBB) that further impedes the drug brain entry, underscore the pressing need for innovative combinational therapy to achieve effective treatment outcomes. Intranasal administration, capable of bypassing BBB by direct transport through olfactory and trigeminal nerves, provides a promising approach for treating neurological disorders. Herein, the guanidinium‐modified calix[5]arene (GC5AY) is developed as a single‐molecule pleuripotent scaffold, demonstrating small size, positive charge and desirable amphiphilicity, which facilitate its efficient traverse of nasal mucosal barrier. The multifunctionality of GC5AY, including inhibiting amyloid fibrosis, scavenging reactive oxygen species and drug delivery, enables it to serve as a sophisticated platform for constructing multi‐target AD therapeutic agents. In light of this, by loading neuroprotective agent Trilobatin (TLB) into the cavity of GC5AY, intranasal administration of the TLB@GC5AY formulation is verified to effectively attenuate the cognitive impairment of AD mice, demonstrating multifaceted pathological improvements, while also possessing good biocompatibility. In response to the growing appeal for combinational therapy of AD, the approach proposed in this study has provided a readily generalizable strategy to fulfill this pursuit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsAdministration, IntranasalAnimalsMiceBlood-Brain BarrierDisease Models, AnimalDrug Delivery SystemsHumansMale

Stichwörter der Autor:innen

Alzheimer's diseasecombinational therapyintranasal administrationmacrocyclic hostssupramolecular materials

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • School of Pharmacy, Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563000, China.
  • College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Frontiers Science Center for New Organic Matter, Collaborative Innovation…
  • Key Laboratory of Macrocyclic and Supramolecular Chemistry of Guizhou Province, Guizhou University, Guiyang, 550025, China.
  • National Engineering Research Center of Pesticide, Nankai University, Tianjin, 300071, China.

ORCID-Profile: Dong-Sheng Guo

Förderung

  • Central Government-Guided Local S&T Special Project of Guizhou Province
  • "'hundred"' level of high-level innovative talents in Guizhou Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Gao, J. M., Li, W. B., Chen, N. N., Yi, Y., Wang, Z. H., Chen, X., Zhao, Y. Y., Yuan, Z. L., Gao, J., Pan, Y. C., Guo, D. S., & Gong, Q. H. (2025). A Single‐Molecule Pleuripotent Scaffold for Combinational Therapy of Alzheimer's Disease via Intranasal Administration. Advanced Science. https://doi.org/10.1002/advs.202511611

Vancouver

Gao JM, Li WB, Chen NN, Yi Y, Wang ZH, Chen X, et al. A Single‐Molecule Pleuripotent Scaffold for Combinational Therapy of Alzheimer's Disease via Intranasal Administration. Advanced Science. 2025. doi:10.1002/advs.202511611

BibTeX
@article{Gao2025,
  author = {Gao, Jian-Mei and Li, Wen-Bo and Chen, Na-Na and Yi, Yang and Wang, Ze-Han and Chen, Xian and Zhao, Yang-Yang and Yuan, Ze-Li and Gao, Jie and Pan, Yu-Chen and Guo, Dong-Sheng and Gong, Qi-Hai},
  title = {A Single‐Molecule Pleuripotent Scaffold for Combinational Therapy of Alzheimer's Disease via Intranasal Administration},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202511611}
}
Kostenlos starten →